Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.
A research group led by Assistant Professor Megumi Aimoto and Professor Akira Takahara at the Faculty of Pharmaceutical Sciences, Toho University, revealed that pyrazole-3 (Pyr3), a selective ...
Verywell Health on MSN
Atrial fibrillation life expectancy
Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Atrial fibrillation (AFib) can lead to strokes and heart failure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results